Cortexyme, Inc. Change of Control Agreements
11 Contracts & Agreements
- Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Dirk Thye, dated as of May 19, 2022 (Filed With SEC on August 9, 2022)
- Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Karen Smith, dated as of May 19, 2022 (Filed With SEC on August 9, 2022)
- Executive Change in Control and Severance Agreement, by and between Cortexyme, Inc. and Brendan Hannah, dated as of May 19, 2022 (Filed With SEC on August 9, 2022)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Ted Monohon, dated as of September 21, 2021 (Filed With SEC on October 29, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Stephen S. Dominy, M.D., dated as of May 19, 2021 (Filed With SEC on August 6, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Michael Detke, dated as of May 21, 2021 (Filed With SEC on August 6, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Leslie Holsinger, dated as of May 18, 2021 (Filed With SEC on August 6, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Christopher Lowe, dated as of May 18, 2021 (Filed With SEC on August 6, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Caryn McDowell, dated as of May 18, 2021 (Filed With SEC on August 6, 2021)
- Change in Control and Severance Agreement, by and between Cortexyme Inc. and Casey C. Lynch, dated as of May 19, 2021 (Filed With SEC on August 6, 2021)
- Form of Executive Change in Control and Severance Agreement (Filed With SEC on May 21, 2020)
